Researchers have created an experimental device that, instead of inhibiting inflammatory proteins in COVID-19 patients, changes the phenotype of circulating white blood cells, helping wean two patients off ECMO.
Imhoff, the team's Diabetes/Endocrinology, Kellogg Eye Center, Nephrology and Rheumatology communicator, joined Michigan Medicine in 2019. She's passionate about storytelling and brand activism. Twitter: @JordynImhoff
What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.
Michigan Medicine ophthalmologists create a scalable algorithm for triaging appointments during the pandemic
Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.
Although additional policies are needed to relieve insulin’s financial burden, researchers find a national cost-sharing cap helps privately insured patients pay less out-of-pocket.